Lioresal

Chronic Pain, Clonus, severe spinal cord origin Spasticity + 11 more

Treatment

20 Active Studies for Lioresal

What is Lioresal

Baclofen

The Generic name of this drug

Treatment Summary

Baclofen is a muscle relaxer that is used to relieve painful or uncomfortable muscle spasms caused by certain medical conditions. It is often prescribed to people with spinal cord injuries to reduce muscle spasticity. There is currently not enough evidence to determine whether baclofen is effective in treating alcohol withdrawal. This drug was approved by the FDA in 1992.

Lioresal

is the brand name

image of different drug pills on a surface

Lioresal Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Lioresal

Baclofen

1977

325

Effectiveness

How Lioresal Affects Patients

Baclofen is a drug that helps with muscle relaxation. It works by decreasing the amount of excitatory signals sent from pre-synaptic neurons and increasing the amount of inhibitory signals sent from post-synaptic neurons. Most commonly, it is taken orally. In one study, it was found to be more effective at reducing spasticity when given directly into the spinal cord than when taken orally. Baclofen can cause drowsiness, poor balance, slow breathing, and a decrease in heart rate. It also can help reduce pain and increase stomach acid production. Additionally, baclofen has anti-inflammatory

How Lioresal works in the body

Baclofen works by blocking signals between the brain and muscles. It binds to GABA receptors, which are found on both pre- and post-synaptic neurons. This blocks the action potentials which would normally be sent to the muscles, leading to relaxation of spasticity. It also causes an influx of potassium into the neuron, which further helps to relax the muscles. Baclofen may also act on some voltage-gated calcium channels, but the clinical significance of this is still unclear.

When to interrupt dosage

The measure of Lioresal is contingent upon the identified affliction, including Spasticity, Multiple Sclerosis and Joint Pain. The dosage is subject to the method of delivery (e.g. Injection - Intrathecal or Tablet - Oral) referenced in the table below.

Condition

Dosage

Administration

Muscle Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Spinal Cord Diseases

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Multiple Sclerosis

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Clonus

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

severe spinal cord origin Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

severe cerebral origin Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Muscle Spasticity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Spinal Cord Injury

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Cerebral Palsy

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Concussion

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Spasm

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Alcoholism

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Muscle Rigidity

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Chronic Pain

10.0 mg, 20.0 mg, , 0.05 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 2.0 mg/mL, 4.0 mg/mL, 10.0 mg/mL, 25.0 mg, 5.0 mg, 1.0 mg/mg, 3.0 mg/mg, 5.0 mg/mL

Tablet, Tablet - Oral, Kit, Topical, Solution, Intrathecal, Solution - Intrathecal, , Oral, Kit - Topical, Injection - Intrathecal, Injection, Injection, solution - Intrathecal, Injection, solution, Cream - Topical, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Solution - Oral, Granule - Oral, Granule, Suspension, Suspension - Oral

Warnings

Lioresal Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Baclofen may interact with Pulse Frequency

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Lioresal.

Common Lioresal Drug Interactions

Drug Name

Risk Level

Description

Azelastine

Major

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Ethanol

Major

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Oliceridine

Major

The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Baclofen is combined with Oliceridine.

Thalidomide

Major

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.

1,2-Benzodiazepine

Minor

Baclofen may increase the central nervous system depressant (CNS depressant) activities of 1,2-Benzodiazepine.

Lioresal Toxicity & Overdose Risk

The lowest toxic dose of baclofen in rats is 145 mg/kg. Symptoms of a baclofen overdose may include confusion, sleepiness, low body temperature, shallow or slow breathing, coma, and seizures. Other rare symptoms can include changes in blood pressure, a slow or fast heartbeat, and vomiting. If someone has overdosed on baclofen, immediate medical attention should be sought. If the patient is awake, vomiting should be induced and their stomach contents should be removed. Unconscious patients should not be encouraged to vomit.

image of a doctor in a lab doing drug, clinical research

Lioresal Novel Uses: Which Conditions Have a Clinical Trial Featuring Lioresal?

451 active studies are currently investigating Lioresal's potential to reduce Clonus, Spasm and severe Spasticity of cerebral origin.

Condition

Clinical Trials

Trial Phases

Spinal Cord Injury

68 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Early Phase 1, Phase 1

Spinal Cord Diseases

10 Actively Recruiting

Not Applicable, Phase 2

Muscle Spasticity

0 Actively Recruiting

Alcoholism

7 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Concussion

92 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1, Phase 4

Multiple Sclerosis

118 Actively Recruiting

Phase 3, Not Applicable, Phase 4, Phase 2, Phase 1, Early Phase 1

Cerebral Palsy

0 Actively Recruiting

Chronic Pain

125 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1

severe spinal cord origin Spasticity

0 Actively Recruiting

severe cerebral origin Spasticity

0 Actively Recruiting

Muscle Spasticity

0 Actively Recruiting

Clonus

0 Actively Recruiting

Spasm

0 Actively Recruiting

Muscle Rigidity

0 Actively Recruiting

Lioresal Reviews: What are patients saying about Lioresal?

4.3

Patient Review

4/21/2009

Lioresal for Muscle Spasms caused by a Spinal Disease

At first, I felt really lightheaded and confused after taking this drug. But now, I can't imagine living without it. It's made life so much easier for me.

4

Patient Review

9/23/2008

Lioresal for Muscle Spasms caused by a Spinal Disease

The medicine works quickly, but the effects don't last very long. Sometimes I have to take a few extra doses when my disease is acting up, but that's to be expected.

2.3

Patient Review

4/13/2010

Lioresal for Muscle Spasms caused by a Spinal Disease

I've been taking this medication for a month now and have yet to see any improvements. My doctor said it would help me with my muscle spasms and cramping, but I still experience those issues just as frequently.

2

Patient Review

1/1/2011

Lioresal for Abnormal Movements of Face Muscles and Tongue

I'm still having muscle spasms and my legs are painful to the touch.

1.3

Patient Review

10/19/2012

Lioresal for Muscle Spasms caused by a Spinal Disease

I've been taking this medication for a few years now, and my doctors have told me that it's the best possible option for my MS. However, I haven't seen much relief in either my facial pain or MS-related pain and stiffness.

1

Patient Review

11/4/2012

Lioresal for Muscle Spasms caused by a Spinal Disease

The very first pill caused me to sleep for an entire day, less half an hour. It also caused me to have a seizure. The doctor ordered me to take 10 mg 3x/day, but I only took one and it had these terrible effects on me.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about lioresal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Lioresal make you sleepy?

"This medicine can cause symptoms like dizziness, drowsiness, vision problems, or clumsiness in some people. Be sure to know how you'll react before doing anything that could be dangerous if you're not alert, coordinated, and able to see well."

Answered by AI

What class of drug is Lioresal?

"Baclofen is a drug that is used to relax muscles and reduce spasms. It is often prescribed for people who have multiple sclerosis or spinal cord injuries. Baclofen can help to relieve muscle pain, stiffness, and spasms."

Answered by AI

Are baclofen pain killers?

"No, Baclofen is not a pain killer. It is a muscle relaxer that can help with pain caused by muscle spasms, but will not help with other types of pain."

Answered by AI

What is Lioresal used to treat?

"Lioresal is a medication that helps to relieve spasticity of voluntary muscle that is a result of disorders such as multiple sclerosis, other spinal lesions, motor neurone disease, transverse myelitis, andtraumatic partial section of the cord."

Answered by AI

Clinical Trials for Lioresal

Have you considered Lioresal clinical trials?

We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.
Go to Trials
Image of Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo in Buffalo, United States.

Mindset Training for MS

18 - 65
All Sexes
Buffalo, NY

People with Multiple Sclerosis (MS) often experience cognitive difficulties such as memory problems, concentration issues, and reduced processing speed. These symptoms can have a negative impact on daily functioning and overall quality of life. Previous research on cognitive rehabilitation has shown that regular training focused on memory and concentration can have positive effects on cognitive functioning, including processing speed, memory, and executive functions that support daily activities. Moreover, fMRI studies (brain scans that measure brain activity) have revealed changes in brain activation following cognitive rehabilitation. Recently, the idea has emerged that a more personalized approach could improve treatment outcomes. Specifically, researchers have identified a link between personality traits and cognitive functioning. Since every individual is different, current cognitive rehabilitation programs often fail to take these personal differences into account. In this project, the investigators aim to enhance the effectiveness of cognitive rehabilitation by focusing more closely on individual characteristics through an app-based training program. Participants will complete a 12-week app training prior to a 6-week cognitive rehabilitation program. The first app focuses on mindset training, supported by a coach. Afterwards, all participants will use a second app designed to train processing speed and memory. In addition to cognitive functioning, the investigators will also examine psychological, (neuro)biological, and social changes using questionnaires and fMRI. This research may provide valuable insights into how cognitive functioning and quality of life in people with MS can be improved. This study is funded by the National MS Fund and is a collaboration between several institutions: the Department of Health, Medical and Neuropsychology at Leiden University (The Netherlands), the University at Buffalo (USA), and Reha Rheinfelden (Switzerland).

Recruiting
1 Prior Treatment

Jacobs School of Medicine and Biomedical Sciences, Neurology, University at Buffalo

Hanneke E Hulst, Prof

Have you considered Lioresal clinical trials?

We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.
Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN

The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).

Phase 4
Waitlist Available

Vanderbilt University Medical Center

Danial Shams, MD

Image of Shirley Ryan AbilityLab in Chicago, United States.

Paired Associative Stimulation + Locomotor Training for Spinal Cord Injury

18 - 75
All Sexes
Chicago, IL

Locomotor recovery is one of the most important goals of individuals with spinal cord injury (SCI). Ambulatory deficits severely impact daily functions resulting in lower quality of life for people living with paralysis due to SCI. Although studies have shown that locomotor training improves locomotor function in people with chronic SCI, the benefits remain limited. Our overall hypothesis is that we can engage additional descending motor pathways, such as the reticulospinal tract (RST), to improve locomotor function in humans with chronic incomplete SCI. In this study we propose to test the effects of a novel intervention that uses repeated paired loud auditory and electrical stimulation of muscle afferents combined with locomotor training on walking speed and voluntary muscle strength.

Phase 1 & 2
Waitlist Available

Shirley Ryan AbilityLab

Dalia De Santis, PhD

Have you considered Lioresal clinical trials?

We made a collection of clinical trials featuring Lioresal, we think they might fit your search criteria.
Go to Trials